Cancer Research

Updates in Mesothelioma Research from ASCO 2017

The American Society of Clinical Oncology (ASCO) held its Annual Meeting on June 2-6, 2017 in Chicago. The Meso Foundation’s CEO, Melinda Kotzian, and Director of Research and Medical Outreach, Gleneara Bates, MS, MSW, PhD (c), had the opportunity to attend the conference and hear the latest news reported in mesothelioma research.
Hedy Lee Kindler, MD, […]


Results Show Encouraging Survival Data: Nintedanib for Mesothelioma

On June 5, Anna Nowak, MD, PhD, of the University of Western Australia and member of the Meso Foundation’s Science Advisory Board, presented phase II results from LUME-Meso, a mesothelioma clinical trial sponsored by Boehringer Ingelheim, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
LUME-Meso is a randomized, double-blind, placebo-controlled trial evaluating […]


Omnibus Bill Passes, Funds Available to Mesothelioma Research Increase

With the passage of the Omnibus budget bill last week, mesothelioma research will now be eligible for $60 million, an increase of $10 million over the amount previously available.
This particular funding is available through the Department of Defense’s Peer-Reviewed Cancer Research Program (PRCRP), a pot of funding available annually to researchers studying any one of […]


Meet a Mesothelioma Nurse: Melissa Culligan

We recently spoke with Melissa Culligan, RN, MS, a mesothelioma nurse at the University of Maryland and a member of the Meso Foundation’s Board of Directors, to ask her some questions about her role in the field in honor of National Nurses Week and National Cancer Research Month. Here’s what she had to say:
At what […]


An Interview with Bonnie Anderson on the Importance of Mesothelioma Research

Diagnosed with mesothelioma in 2002, Bonnie Anderson is a 15-year warrior. Throughout this time, she and her husband, John, have been ardent supporters of the Meso Foundation and have established themselves as leading advocates within the mesothelioma community. Through the Mesothelioma Applied Research Foundation’s peer-review research grant program, they personally funded two research studies:

Exploiting Nf2/Merlin […]